FINE N SCOTT - Insider Non-Derivative Transactions at Cyclo Therapeutics, Inc. (CYTH) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Oct 20, 2023, FINE N SCOTT's relationship to Cyclo Therapeutics, Inc. (CYTH) is Director,Officer (Chief Executive Officer), and currently has 743,804 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CYTH insiders.

Data Source: SEC.
FINE N SCOTT - Insider Non-Derivative Transactions of CYTH Common Stock
FINE N SCOTT - Insider Non-Derivative Transactions at CYTH
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Oct 21, 2023 X -- (Common Stock) 299402 0.71 743804
Apr 21, 2023 P -- (Common Stock) 299402 0.71 444402